Sodium benzoate treatment decreased amyloid beta peptides and improved cognitive function among patients with Alzheimer's disease: secondary analysis of a randomized clinical trial.

Transl Psychiatry · 2025 · PMC12326001 · PMID 40764372

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In addition, benzoate therapy also showed a trend in decreasing the Aβ 1–42 level and the ratio of Aβ 1–42/Aβ 1–40, albeit insignificantly (Table 1 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.